Phase 1 Clinical Trials: First-in-Human Studies Explained
Detailed guide to Phase 1 clinical trials, the first step in testing new treatments in humans.
Detailed guide to Phase 1 clinical trials, the first step in testing new treatments in humans.
Detailed guide to Phase 1 clinical trials, the first step in testing new treatments in humans.
Phase 1 trials are the first time a new treatment is tested in humans after extensive preclinical research. These studies typically involve 20 to 80 participants and focus on determining safety, tolerability, and how the body processes the treatment. Phase 1 studies are closely monitored and proceed cautiously with dose escalation.
Phase 1 trials often use dose escalation designs where early participants receive lower doses and later participants may receive higher doses, provided earlier doses were well-tolerated. This approach helps identify the maximum tolerated dose while maintaining safety. Participants are informed about which dose level the study is currently testing.
Learn the basics of clinical trials, including what they are, why they matter, and how you can participate.
Learn about the rigorous safety protocols, ethical guidelines, and regulatory oversight that protect clinical trial participants.
A comprehensive breakdown of the four phases of clinical trials and what each phase means for participants and researchers.
Understand the differences between observational studies and interventional clinical trials and what each involves.
This guide is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or any medical treatment. StudyReward does not provide medical recommendations or endorse specific clinical trials.